Rational development of multicomponent mRNA vaccine candidates against mpox

Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study

(2022) Eloy José Tarín-Vicente et al.   LANCET

Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus

(2022) Joana Isidro et al.   NATURE MEDICINE

Monkeypox virus outbreak: can evolution guide us to new treatments or vaccines?

(2022) eBioMedicine   EBioMedicine

Monkeypox emergency: Urgent questions and perspectives

(2022) Stefan Rothenburg et al.   CELL

Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals

(2022) Luca M. Zaeck et al.   NATURE MEDICINE

Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans

(2022) Alba Grifoni et al.   Cell Host & Microbe

SARS-CoV-2 Vaccines

(2021) C. Buddy Creech et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge

(2021) Eric M. Mucker et al.   JOURNAL OF VIROLOGY

A Thermostable mRNA Vaccine against COVID-19

(2020) Na-Na Zhang et al.   CELL

Analgesia during Monkeypox Virus Experimental Challenge Studies in Prairie Dogs (Cynomys ludovicianus)

(2019) Christina L Hutson et al.   Journal of the American Association for Laboratory Animal Science

Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge

(2019) Andrew T. Russo et al.   VACCINE

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

(2016) Iuliia Gilchuk et al.   CELL

BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge

(2015) Valentina Franceschi et al.   PLoS Neglected Tropical Diseases

CD8 T Cells Use IFN-  To Protect against the Lethal Effects of a Respiratory Poxvirus Infection

(2014) J. Goulding et al.   JOURNAL OF IMMUNOLOGY

Primary Human Macrophages Serve as Vehicles for Vaccinia Virus Replication and Dissemination

(2014) D. Byrd et al.   JOURNAL OF VIROLOGY

Anatomically Restricted Synergistic Antiviral Activities of Innate and Adaptive Immune Cells in the Skin

(2013) Heather D. Hickman et al.   Cell Host & Microbe

Memory CD8 + T Cells Can Outsource IFN-γ Production but Not Cytolytic Killing for Antiviral Protection

(2013) Sanda Remakus et al.   Cell Host & Microbe

Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus Macaques

(2013) G. J. Hatch et al.   JOURNAL OF VIROLOGY

Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge

(2010) Lauren A. Hirao et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccinia virus vaccines: Past, present and future

(2009) Bertram L. Jacobs et al.   ANTIVIRAL RESEARCH

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE® against aerosolized rabbitpox virus in a rabbit model

(2009) Nicole L. Garza et al.   VACCINE

Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates

(2009) Jay W. Hooper et al.   VACCINE

Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation

(2008) E. Hammarlund et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies

(2008) Joseph W. Golden et al.   VACCINE